Suchergebnisse - "Somatostatin receptor ligand"

PubPharm (204)

1

Predictors of biochemical response to somatostatin receptor ligands in acromegaly

enthalten in: Best practice & research. Clinical endocrinology & metabolism | 2024

von Marazuela, M. | Martínez-Hernandez, R. | Marques-Pamies, M. | +3

2

New Treatments for Acromegaly in Development

enthalten in: The Journal of clinical endocrinology and metabolism | 2024

von Gadelha, M. | Gadelha, A. | Kasuki, L.

3

Immunological signatures and predictive biomarkers for first-generation somatostatin receptor ligand resistance in Acromegaly

enthalten in: Journal of neuro-oncology | 2024

von Luo, M. | Yu, J. | Tang, R.

4

Treatment of acromegaly with oral octreotide

enthalten in: Best practice & research. Clinical endocrinology & metabolism | 2024

von Remba-Shapiro, I. | Nachtigall, L.

5

Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma : A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues

enthalten in: Endocrine, metabolic & immune disorders drug targets | 2024

von Raia, S. | Chiloiro, S. | Giampietro, A. | +9

6

Biomarkers of response to treatment in acromegaly

enthalten in: Expert review of endocrinology & metabolism | 2024

von Kasuki, L. | Lamback, E. | Antunes, X. | +1

7

Methodology of the SORENTO clinical trial : a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET

enthalten in: Trials | 2024

von Singh, S. | Ferone, D. | Capdevila, J. | +8

8

Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET

enthalten in: Trials | 2024

von Singh, S. | Ferone, D. | Capdevila, J. | +8

9

The Effect of Metformin Treatment on Disease Control in Patients with Acromegaly

enthalten in: Endocrine, metabolic & immune disorders drug targets | 2024

von Sahin, H. | Sahin, S. | Sarac, B. | +3

10

Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours

enthalten in: Advances in therapy | 2023

von Jørgensen, J. | de Herder, W. | Martin, W. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]